Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
Mar. 31, 2025	Mar. 31, 2024
Revenues
License and collaboration revenue	$ 52	$ 529
Operating expenses
Research and development	27,467	17,210
General and administrative	14,789	5,788
Total operating expenses	42,256	22,998
Loss from operations	(42,204)	(22,469)
Other income (expense), net:
Interest income, net	7,747	5,544
Other income (expense), net	5	(9)
Total other income, net	7,752	5,535
Net loss and comprehensive loss	$ (34,452)	$ (16,934)
Net loss per share , basic	$ (0.45)	$ (0.36)
Net loss per share , diluted	$ (0.45)	$ (0.36)
Weighted average shares of common stock outstanding, basic	76,187,621	47,064,768
Weighted average shares of common stock outstanding, diluted	76,187,621	47,064,768

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

Name:	us-gaap_EarningsPerShareBasic
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.